Endothelial function and the regulation of muscle protein anabolism in older adults

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue SUPPL1, 2013, Pages

  Timmerman, K L ^a   Volpi, E ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Endothelial dysfunction; Insulin resistance; Muscle protein metabolism; Sarcopenia

Indexed keywords

ENDOTHELIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MUSCLE PROTEIN; NITRIC OXIDE; OMEGA 3 FATTY ACID; VASODILATOR AGENT;

AGING; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; EXERCISE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; OXIDATIVE STRESS; PROTEIN INTAKE; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; REVIEW; SARCOPENIA; VASOCONSTRICTION; VASODILATATION;

ENDOTHELIAL DYSFUNCTION; INSULIN RESISTANCE; MUSCLE PROTEIN METABOLISM; SARCOPENIA;

AGED; AGING; ENDOTHELIUM; HUMANS; METABOLISM; MUSCLE PROTEINS; MUSCLE, SKELETAL; SARCOPENIA;

EID: 84890886901     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.03.013     Document Type: Review

References (62)

1. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther 2011.
2. Iannuzzi-Sucich M., Prestwood K.M., Kenny A.M. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002, 57:M772-M777.
3. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002, 50:889-896.
4. Gerhard M., Roddy M.A., Creager S.J., Creager M.A. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27:849-853.
5. Newcomer S.C., Leuenberger U.A., Hogeman C.S., Proctor D.N. Heterogeneous vasodilator responses of human limbs: influence of age and habitual endurance training. Am J Physiol Heart Circ Physiol 2005, 289:H308-H315.
6. Rasmussen B.B., Fujita S., Wolfe R.R., et al. Insulin resistance of muscle protein metabolism in aging. FASEB J 2006, 20:768-769.
7. Brandes R.P., Fleming I., Busse R. Endothelial aging. Cardiovasc Res 2005, 66:286-294.
8. Fujita S., Glynn E.L., Timmerman K.L., Rasmussen B.B., Volpi E. Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia 2009, 52:1889-1898.
9. Timmerman K.L., Lee J.L., Fujita S., et al. Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes 2010, 59:2764-2771.
10. Baumgartner R.N., Koehler K.M., Gallagher D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
11. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010, 39:412-423.
12. Janssen I., Baumgartner R.N., Ross R., Rosenberg I.H., Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004, 159:413-421.
13. Sayer A.A., Syddall H.E., Martin H.J., Dennison E.M., Anderson F.H., Cooper C. Falls, sarcopenia, and growth in early life: findings from the Hertfordshire cohort study. Am J Epidemiol 2006, 164:665-671.
14. Cawthon P.M., Marshall L.M., Michael Y., et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007, 55:1216-1223.
15. Rolland Y., Czerwinski S., Abellan V.K., et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008, 12:433-450.
16. Bohe J., Low A., Wolfe R.R., Rennie M.J. Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol 2003, 552:315-324.
17. Fujita S., Dreyer H.C., Drummond M.J., et al. Nutrient signalling in the regulation of human muscle protein synthesis. J Physiol 2007, 582:813-823.
18. Volpi E., Sheffield-Moore M., Rasmussen B.B., Wolfe R.R. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA 2001, 286:1206-1212.
19. Cuthbertson D., Smith K., Babraj J., et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 2005, 19:422-424.
20. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 2005, 82:1065-1073.
21. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 2006, 291:E381-E387.
22. Paddon-Jones D., Sheffield-Moore M., Katsanos C.S., Zhang X.J., Wolfe R.R. Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp Gerontol 2006, 41:215-219.
23. Rieu I., Balage M., Sornet C., et al. Increased availability of leucine with leucine-rich whey proteins improves postprandial muscle protein synthesis in aging rats. Nutrition 2007, 23:323-331.
24. Symons T.B., Sheffield-Moore M., Wolfe R.R., Paddon-Jones D. A moderate serving of high-quality protein maximally stimulates skeletal muscle protein synthesis in young and elderly subjects. J Am Diet Assoc 2009, 109:1582-1586.
25. Koopman R., Walrand S., Beelen M., et al. Dietary protein digestion and absorption rates and the subsequent postprandial muscle protein synthetic response do not differ between young and elderly men. J Nutr 2009, 139:1707-1713.
26. Volpi E., Mittendorfer B., Rasmussen B.B., Wolfe R.R. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 2000, 85:4481-4490.
27. Guillet C., Prod'homme M., Balage M., et al. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J 2004, 18:1586-1587.
28. Vincent M.A., Montagnani M., Quon M.J. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003, 3:279-288.
29. Wilkes E.A., Selby A.L., Atherton P.J., et al. Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. Am J Clin Nutr 2009, 90:1343-1350.
30. Timmerman K.L., Lee J.L., Dreyer H.C., et al. Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelial-dependent vasodilation and mammalian target of rapamycin complex 1 signaling. J Clin Endocrinol Metab 2010.
31. Seals D.R., Jablonski K.L., Donato A.J. Aging and vascular endothelial function in humans. Clin Sci (Lond) 2011, 120:357-375.
32. Jiang Z.Y., Zhou Q.L., Chatterjee A., et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999, 48:1120-1130.
33. Shemyakin A., Salehzadeh F., Bohm F., et al. Regulation of glucose uptake by endothelin-1 in human skeletal muscle invivo and invitro. J Clin Endocrinol Metab 2010, 95:2359-2366.
34. Donato A.J., Gano L.B., Eskurza I., et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2009, 297:H425-H432.
35. Verma S., Arikawa E., Lee S., Dumont A.S., Yao L., McNeill J.H. Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan. Can.J.Physiol Pharmacol 2002, 80:980-986.
36. Taddei S., Virdis A., Ghiadoni L., et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001, 38:274-279.
37. Eskurza I., Myerburgh L.A., Kahn Z.D., Seals D.R. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J Physiol 2005, 568:1057-1065.
38. Higashi Y., Sasaki S., Nakagawa K., et al. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production. Atherosclerosis 2006, 186:390-395.
39. Bruunsgaard H., Pedersen A.N., Schroll M., Skinhoj P., Pedersen B.K. Decreased natural killer cell activity is associated with atherosclerosis in elderly humans. Exp Gerontol 2001, 37:127-136.
40. Zanni F., Vescovini R., Biasini C., et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 2003, 38:981-987.
41. Bruunsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003, 23:15-39.
42. Payne G.W. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation 2006, 13:343-352.
43. Csiszar A., Labinskyy N., Smith K., Rivera A., Orosz Z., Ungvari Z. Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol 2007, 170:388-398.
44. Pierce G.L., Lesniewski L.A., Lawson B.R., Beske S.D., Seals D.R. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 2009, 119:1284-1292.
45. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
46. Verma S., Wang C.H., Li S.H., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
47. Landmesser U., Dikalov S., Price S.R., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111:1201-1209.
48. Tatchum-Talom R., Martin D.S. Tempol improves vascular function in the mesenteric vascular bed of senescent rats. Can J Physiol Pharmacol 2004, 82:200-207.
49. Fujita S., Rasmussen B.B., Cadenas J.G., et al. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 2007, 56:1615-1622.
50. Pierce G.L., Eskurza I., Walker A.E., Fay T.N., Seals D.R. Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci (Lond) 2011, 120:13-23.
51. Kohut M.L., McCann D.A., Russell D.W., et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006, 20:201-209.
52. Scheele C., Nielsen S., Pedersen B.K. ROS and myokines promote muscle adaptation to exercise. Trends Endocrinol Metab 2009, 20:95-99.
53. Li Y.P., Chen Y., John J., et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005, 19:362-370.
54. Dickinson K.M., Keogh J.B., Clifton P.M. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 2009, 89:485-490.
55. McCall D.O., McGartland C.P., McKinley M.C., et al. Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 2009, 119:2153-2160.
56. Shah A.P., Ichiuji A.M., Han J.K., et al. Cardiovascular and endothelial effects of fish oil supplementation in healthy volunteers. J Cardiovasc Pharmacol Ther 2007, 12:213-219.
57. Smith G.I., Atherton P., Reeds D.N., et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 2011, 93:402-412.
58. Egert S., Stehle P. Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care 2011, 14:121-131.
59. Kerr S.M., Livingstone M.B., McCrorie T.A., Wallace J.M. Endothelial dysfunction associated with obesity and the effect of weight loss interventions. Proc Nutr Soc 2011, 70:418-425.
60. Calder P.C., Ahluwalia N., Brouns F., et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011, 106(Suppl. 3):S5-78.
61. Haspicova M., Milek D., Siklova-Vitkova M., et al. Post-prandial endothelial dysfunction is ameliorated following weight loss in obese premenopausal women. Med Sci Monit 2011, 17:CR634-CR639.
62. Villareal D.T., Smith G.I., Shah K., Mittendorfer B. Effect of weight loss on the rate of muscle protein synthesis during fasted and fed conditions in obese older adults. Obesity 2011 Sep 22, [Epub ahead of print].